Nicholas Watkins

Executive Summary

We will develop a protein-production technology that addresses crucial problems in biosecurity and healthcare by maximizing production and system portability while minimizing production latency and cost. Our first-generation platform would leverage cell-free protein synthesis, microfluidics, and nanostructures, providing a foundation for delivering a rapidly deployable, versatile production platform for biologic therapeutics.